The Heart Failure Policy Network

arrow-splash

Helping advance meaningful policy change on heart failure

The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from Novartis Pharma and Vifor Pharma. Additional support for The handbook launch in September 2018 has been provided by Bayer AG. The content produced by the Network is not biased to any specific treatment or therapy, and is endorsed and owned by the Network’s members, who have full editorial control. All members provide their time for free.

A lot of progress has been made in recent years, but adoption of proven techniques is still far below where it should be. Visit our website to view the materials we have developed for policymakers to provide the best delivery models. #HeartFailure bit.ly/HF-Handbook pic.twitter.com/tv70x7KCdS